Détails du produit
Source
Biotinylated FMC63 scFv, Fc, Avitag™ is a recombinant single-chain variable fragment derived from the mouse monoclonal antibody clone FMC63 and expressed in HEK293 cells.
Antibody Type
Recombinant Monoclonal
Host Species
Mouse
Reactivity
Human
Immunogen
CD19
Conjugate
Biotin
Specificity
Specifically recognizes the CD19.
Application
ApplicationRecommended UsageELISA1:5-1:50Purification
Affinity purification.
Aggregation
Less than 5%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Bioactivity-ELISA

A microplate was coated with FMC63 monoclonal antibody, Mouse IgG2a, at 1 μg/mL. Serially diluted Rabbit Anti-Mouse FMC63 Polyclonal Antibody was added, followed by Biotinylated FMC63 scFv-Fc-Avitag at 2 μg/mL. Binding was detected using HRP-conjugated streptavidin. The QC-tested sensitivity was 78 ng/mL (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire

Introduction de fond
Progrès de frontière
- Nom anglais:
B-lymphocyte antigen CD19
- Catégorie:
- Nombre de médicaments répertoriés:
14 Détails
- Nombre de médicaments cliniques:
435 Détails
- Étape de développement la plus élevée:
Approved



















